375 related articles for article (PubMed ID: 17391385)
21. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.
Balassiano IT; dos Santos-Filho J; Vital-Brazil JM; Nouér SA; Souza CR; Brazier JS; Ferreira Ede O; Domingues RM
Antonie Van Leeuwenhoek; 2011 Feb; 99(2):249-55. PubMed ID: 20623188
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of toxin A-negative, toxin B-positive variant strains of Clostridium difficile isolated in Korea.
Kim SJ; Kim H; Seo Y; Yong D; Jeong SH; Chong Y; Lee K
Diagn Microbiol Infect Dis; 2010 Jun; 67(2):198-201. PubMed ID: 20338708
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
[TBL] [Abstract][Full Text] [Related]
24. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.
Kim H; Jeong SH; Roh KH; Hong SG; Kim JW; Shin MG; Kim MN; Shin HB; Uh Y; Lee H; Lee K
Korean J Lab Med; 2010 Oct; 30(5):491-7. PubMed ID: 20890081
[TBL] [Abstract][Full Text] [Related]
25. [Profile of toxigenicity of Clostridium difficile strains isolated from paediatric patients with clinical diagnosis of antibiotic associated diarrhea (AAD)].
Wultańska D; Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Luczak M
Med Dosw Mikrobiol; 2005; 57(4):377-82. PubMed ID: 16773831
[TBL] [Abstract][Full Text] [Related]
26. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
[TBL] [Abstract][Full Text] [Related]
27. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of AP-PCR methods, ribotyping (PCR-ribotyping) and pulsed-field electrophoresis (PFGE) for strains of Clostridium difficile producing toxin B and not producing toxin A].
Pituch H; van Belkum A; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2003; 55(1):53-60. PubMed ID: 12908415
[TBL] [Abstract][Full Text] [Related]
29. Emergence of Clostridium difficile-associated disease in North America and Europe.
Kuijper EJ; Coignard B; Tüll P; ; ;
Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399
[TBL] [Abstract][Full Text] [Related]
30. Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures.
Doing KM; Hintz MS; Keefe C; Horne S; LeVasseur S; Kulikowski ML
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):129-34. PubMed ID: 20117349
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the pathogenicity locus in Clostridium difficile strains.
Cohen SH; Tang YJ; Silva J
J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
[TBL] [Abstract][Full Text] [Related]
32. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Clostridium difficile toxinotypes in infected patients at a tertiary care center in Lebanon.
Moukhaiber R; Araj GF; Kissoyan KA; Cheaito KA; Matar GM
J Infect Dev Ctries; 2015 Jul; 9(7):732-5. PubMed ID: 26230123
[TBL] [Abstract][Full Text] [Related]
34. [Laboratory-based evaluation of TOX A/B QUIK CHEK "NISSUI" to detect toxins A and B of clostridium difficile].
Nakasone I; Shiohira CM; Yamane N
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2007; 18(2):109-16. PubMed ID: 18154439
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of two enzyme immunoassay for detection of Clostridium difficile toxin A and toxin B].
Shin BM; Yoo SJ; Oh HJ
Korean J Lab Med; 2009 Apr; 29(2):122-6. PubMed ID: 19411778
[TBL] [Abstract][Full Text] [Related]
36. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile.
Elliott B; Reed R; Chang BJ; Riley TV
Anaerobe; 2009 Dec; 15(6):249-51. PubMed ID: 19723585
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital.
Martirosian G; Szczesny A; Cohen SH; Silva J
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):153-5. PubMed ID: 15964504
[TBL] [Abstract][Full Text] [Related]
38. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
[TBL] [Abstract][Full Text] [Related]
39. Fatal enterocolitis in Asian elephants (Elephas maximus) caused by Clostridium difficile.
Bojesen AM; Olsen KE; Bertelsen MF
Vet Microbiol; 2006 Sep; 116(4):329-35. PubMed ID: 16737787
[TBL] [Abstract][Full Text] [Related]
40. Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland: a survey of Irish microbiology laboratories.
Fitzpatrick F; Oza A; Gilleece A; O'Byrne AM; Drudy D;
J Hosp Infect; 2008 Apr; 68(4):315-21. PubMed ID: 18353502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
